Publications
 

Research from SF CAN

​

​

Breast Cancer Team Publications:
 

1. Guan A, Lichtensztajn D, Oh D, et al. Breast Cancer in San Francisco: Disentangling Disparities at the Neighborhood Level. Cancer Epidemiol Biomarkers Prev. 2019;28(12):1968-1976.

​

Colorectal Cancer Team Publications:
 

1. Somsouk M, Rachocki C, Mannalithara A, Garcia D, Laleau V, Grimes B, Issaka RB, Chen E, Vittinghoff E, Shapiro JA, Ladabaum U. Effectiveness and cost of organized outreach for colorectal cancer screening: A randomized controlled trial. J Natl Cancer Inst. 2019.

2. Walsh J, Potter M, Salazar R, Ozer E, Gildengorin G, Dass N, Green L. PreView: A randomized trial of a multi-site intervention in diverse primary care to increase rates of age-appropriate cancer screening. J Gen Intern Med. 2019.

3. Wang A, Rachocki C, Shapiro JA, Issaka RB, Somsouk M. Low literacy level instructions and reminder calls improve patient handling of fecal immunochemical test samples. Clin Gastroenterol Hepatol. 2019;17(9):1822-1828.

4. Issaka RB, Rachocki C, Huynh M, Chen E, Somsouk M. Standardized workflows improve colonoscopy follow-up after abnormal fecal immunochemical tests in a safety-net system. Dig Dis Sci. 2020.

5. Lee B, Keyes E, Rachocki C, Grimes B, Chen E, Vittinghoff E, Ladabaum U, Somsouk M. Increased colorectal cancer screening sustained with mailed fecal immunochemical test outreach. Clin Gastroenterol Hepatol. 2021. 

6. Wang A, Lee B, Patel S, Whitaker E, Issaka RB, Somsouk M. Selection of patients for large mailed fecal immunochemical test colorectal cancer screening outreach programs: A systematic review. J Med Screen. 2021.

7. Walsh WJ, Potter MB, Ozer OE, Gildengorin GG, Dass DN, Green LG. Evaluating the sustainability of a cancer screening intervention through a PRISM: The PreView experience. Prev Med Rep. 2021;23:101443.

8. Burns S, Griffith M, Patel S, Sarkar U, Somsouk M. Electronic coding for abnormal fecal immunochemical test is associated with increased colonoscopy completion. Am J Gastroenterol. 2022;117:1-3.

9. McClellan SP, Canchola AJ, Potter MB, Gomez SL, Somsouk M. Neighborhood socioeconomic status and the effectiveness of colorectal cancer screening outreach with mailed fecal immunochemical tests within a safety net healthcare system in San Francisco, CA: A subgroup analysis of a randomized controlled trial. Prev Med. 2023;167:107388.

10.  Burns S, Wang J, Somsouk M. Effect of mailed fecal immunochemical test outreach for patients newly eligible for colorectal cancer screening. Dig Dis Sci. 2023;68(6):2315-2317.

11. Khoong EC, Rivadeneira NA, Pacca L, Schillinger D, Lown D, Babaria P, Gupta N, Pramanik R, Tran H, Whitezell T, Somsouk M, Sarkar U. Extent of follow-up on abnormal cancer screening in multiple California public hospital systems: A retrospective review. J Gen Intern Med. 2023;38(1):21-29.

12. Santiago-Rodriguez EJ, Hoeft K, Lugtu K, McGowen M, Ofman D, Adler J, Somsouk M, Potter MB. Implementation of a novel program to support colorectal cancer screening in a community health center consortium before and after the onset of COVID-19: A qualitative study of stakeholders’ perspectives. Implement Sci Commun. 2023;4(1):54.

13. Patel S, Sewell JL, Bhuket T, Somsouk M. Delivering high-quality, efficient gastroenterology care to vulnerable and underserved populations: Special considerations and possible solutions. Clin Gastroenterol Hepatol. 2023;21(13):3213-3216.e1.

14. McClellan SP, Patel S, Uy-Smith E, Gregory B, Neuhaus JM, Potter MB, Somsouk M. Colorectal cancer screening: A multicomponent intervention to increase uptake in patients aged 45-49. J Am Board Fam Med. 2024;37(4):660-670.

15. Somsouk M, Lee B, Potter MB. Opportunity and promise of stool-based organized colorectal cancer screening programs. Tech Innov Gastrointest Endosc. In press.

16. McClellan SP, Khan T, Rafferty H, Wong J, La S, Patel S, Somsouk M. The effect of mailed outreach on FIT completion among patients aged 45-50 in a safety net healthcare system. Cancer Causes Control. 2024.

17. Burns S, Griffith M, Patel S, Sarkar U, Somsouk M. Electronic Coding for Abnormal Fecal Immunochemical Test Is Associated With Increased Colonoscopy Completion. Am J Gastroenterol. 2024;119(7):1431-1432.​

​

Liver Cancer Team Publications:
 

1. Facente SN, Grebe E, Burk K, Morris MD, Murphy EL, Mirzazadeh A, Smith AA, Sanchez MA, Evans JL, Nishimura A, Raymond HF; End Hep C SF. Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for elimination. PLoS One. 2018;13(4):e0195575. doi:10.1371/journal.pone.0195575.

2. Morris MD, Mirzazadeh A, Evans JL, Briceno A, Coffin P, Hahn JA, Page KA. Treatment cascade for hepatitis C virus in young adult people who inject drugs in San Francisco: Low number treated. Drug Alcohol Depend. 2019;198:133-135.

3. Rivadeneira NA, Hoskote M, Le GM, Nguyen TT, Nápoles AM, Pasick RJ, Sarkar U, Hiatt RA. Advancing cancer control in San Francisco: Cancer screening in under-represented populations. Am J Prev Med. 2020;58(1):e1-e9.

4. Chu JN, Stewart SL, Gildengorin G, Wong C, Lam H, McPhee SJ, Chen MS, Bastani R, Maxwell AE, Taylor VM, Nguyen TT. Effect of a media intervention on hepatitis B screening among Vietnamese Americans. Ethn Health. 2019;24:1-14.

5. Kim NJ, Locke CJ, Park H, Magee C, Bacchetti P, Khalili M. Race and hepatitis C care continuum in an underserved birth cohort. J Gen Intern Med. 2019;34(10):2005-2013.

6. Beck KR, Kim NJ, Khalili M. Direct acting antivirals improve HCV treatment initiation and adherence among underserved African Americans. Ann Hepatol. 2018;17(3):413-418.

7. Mukhtar NA, Kathpalia P, Hilton JF, Lau G, Yu A, Grumbach K, Nguyen TT, Chan D, Khalili M. Provider, patient, and practice factors shape hepatitis B prevention and management by primary care providers. J Clin Gastroenterol. 2017;51(7):626-631.

8. Mukhtar NA, Fox RK. Hepatitis C virus cure and obesity: Watch the weight. J Gen Intern Med. 2020;35(10):2836-2837.

9. Wilson EC, Turner C, Lin J, McFarland W, Burk K, Raymond HF. Hepatitis C seroprevalence and engagement in related care and treatment among trans women. J Viral Hepat. 2019;26(7):923-925. doi:10.1111/jvh.13089.

10. Gaudino A, Gay B, Garmon C, Selick M, Vreeland R, Burk K, Huriaux E, Facente SN, Luetkemeyer A, Waters P, Graham CS. Localized US efforts to eliminate hepatitis C. Infect Dis Clin North Am. 2018;32(2):293-311.

​

Prostate Cancer Team Publications:
 

1. Nie J, Palmer NR, Pasick RJ, et al. Smarter Screening and Treatment (S3T): Mitigating Harm via Age- and Prostate-Specific Antigen-Stratified Screening. J Gen Intern Med. 2025. doi:10.1007/s11606-025-09737-7.

2. Palmer NR, Smith AN, Campbell BA, et al. Navigation programs relevant for African American men with prostate cancer: A scoping review protocol. Syst Rev. 2022;11:122. doi:10.1186/s13643-022-01993-6.

3. Palmer NR, Shim JK, Kaplan CP, et al. Ethnographic investigation of patient-provider communication among African American men newly diagnosed with prostate cancer: A study protocol. BMJ Open. 2020;10:e035032. doi:10.1136/bmjopen-2019-035032.

​

Tobacco Cessation for People Experiencing Homelessness publications:
 

1. Vijayaraghavan M, Apollonio DE. Engaging adults experiencing homelessness in smoking cessation through large-scale community service events. Health Promot Pract. 2019 May;20(3):325-327. doi: 10.1177/1524839919835280. Epub 2019 Mar 7. PMID: 30845844; PMCID: PMC7263353.

2. Vijayaraghavan M, Elser H, Frazer K, Lindson N, Apollonio D. Interventions to reduce tobacco use in people experiencing homelessness. Cochrane Database Syst Rev. 2020 Dec;12(12):CD013413. doi: 10.1002/14651858.CD013413.pub2. PMID: 33284989; PMCID: PMC8130995.

3. Hartman-Filson M, Chen J, Lee P, Phan M, Apollonio DE, Kroon L, Donald F, Vijayaraghavan M. A community-based tobacco cessation program for individuals experiencing homelessness. Addict Behav. 2022 Jun; 129:107282. doi: 10.1016/j.addbeh.2022.107282. Epub 2022 Feb 16. PMID: 35184003.

4. De Los Reyes G, Ng A, Valencia Chavez J, Apollonio DE, Kroon L, Lee P, Vijayaraghavan M. Evaluation of a pharmacist-linked smoking cessation intervention for adults experiencing homelessness. Subst Use Misuse. 2023 Jul 3:1-9. doi: 10.1080/10826084.2023.2231060. Epub ahead of print. PMID: 37401115.

Youth Tobacco & Vaping Cessation publications: 

 

1. Ling PM, Lisha NE, Neilands TB, Jordan JW. Join the commune: A controlled study of social branding influencers to decrease smoking among young adult hipsters. Am J Health Promot. 2020;34(7):754-761. doi:10.1177/0890117120904917.

2. Pravosud V, Holmes LM, Lempert LK, Ling PM. Impact of policies restricting flavors in non-cigarette tobacco products: A study of vape shops in San Francisco and Alameda Counties.

3. Kim M, Olson S, Jordan J, Ling PM. Peer crowd-based targeting in e-cigarette advertisements: A qualitative study to inform counter-marketing. BMC Public Health. 2020;20:32. doi:10.1186/s12889-019-8126-x.

4. Vogel EA, Guillory J, Ling PM. Sponsorship disclosures and perceptions of e-cigarette Instagram posts. Tob Regul Sci. 2020;6(5):355-368.

5. Watkins SL, Thrul J, Max W, Ling PM. Real-world effectiveness of smoking cessation strategies for young and older adults: Findings from a nationally representative cohort. Nicotine Tob Res. 2020;22(9):1560-1568.

6. Toledo G, McQuoid J, Ling PM. “It's not too aggressive”: Key features of social branding anti-tobacco interventions for high-risk young adults. Health Promot Pract. 2020. doi:10.1177/1524839920910372.

7. Vyas P, Ling P, Gordon B, Callewaert J, Dang A, Smith D, Chan B, Glantz S. Compliance with San Francisco's flavored tobacco sales prohibition. Tob Control. 2020.

8. Nguyen N, Neilands TB, Lisha NE, Lyu JC, Olson SS, Ling PM. Longitudinal associations between use of tobacco and cannabis among people who smoke cigarettes in real-world smoking cessation treatment. J Addict Med. 2021.

9. McQuoid J, Keane H, Ling PM. Purposeful play: Exploring a bar-based, anti-tobacco intervention for young adults. Drugs Educ Prev Policy. 2021. doi:10.1080/09687637.2021.1932753.

10. Holmes LM, Thrul J, Warren N, Ling PM. Local variation in cannabis use patterns among young adults in the San Francisco Bay Area. Spat Spatiotemporal Epidemiol. 2021;37:100418. doi:10.1016/j.sste.2021.100418.

11. Lee A, Chang AA, Lyu JC, Ling PM, Hsia SL. Characterizing participant perceptions about smoking-cessation pharmacotherapy and e-cigarettes from Facebook smoking-cessation support groups. Int J Environ Res Public Health. 2022;19(12):7314. doi:10.3390/ijerph19127314.

12. Lyu JC, Afolabi A, White JS, Ling PM. Perceptions and aspirations toward peer mentoring in social media-based e-cigarette cessation interventions for adolescents and young adults: A focus group study. JMIR Form Res. 2022. doi:10.2196/42538.

13. Lyu JC, Olson SS, Ramo DE, Ling PM. Delivering vaping cessation interventions to adolescents and young adults on Instagram: Protocol for a randomized controlled trial. BMC Public Health. 2022;22:2311. doi:10.1186/s12889-022-14606-7.

14. Nguyen N, Holmes LM, Pravosud V, Cohen BE, Ling PM. Changes in perceived harms of tobacco and cannabis and their correlations with use: A panel study of young adults, 2014-2020. Addict Behav. 2023;144:107758. doi:10.1016/j.addbeh.2023.107758.

15. Lyu JC, Meacham MC, Nguyen N, Ramo D, Ling PM. Factors associated with abstinence among young adult smokers enrolled in a real-world social media smoking cessation program. Nicotine Tob Res. 2024;26(suppl 1). doi:10.1093/ntr/ntad170.

​​

Menthol Tobacco Policy Publications: 
 

1. Mills SD, McGruder CO, Yerger VB. The African American Tobacco Control Leadership Council: Advocating for a menthol cigarette ban in San Francisco, California. Tob Control. 2021;30:e150-e153. 

2. Gardiner PS. The African Americanization of menthol cigarette use in the United States. Nicotine Tob Res. 2004;6(suppl 1):S55-S65.

​​